C+79/100
Desk Score
Dispatch #61
AskRx
AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.
Visit AskRx ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
- Semaglutide
- $349/mo (all doses, brand-name)
- Tirzepatide
- $299/mo (2.5 mg dose, brand-name)
- Coverage
- All 50 states
- Brand-name
- Yes
Line AskRx up against its closest alternatives. Or go one-on-one: AskRx vs CoreAge Rx.
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency76/100
State access86/100
Molecule range79/100
Onboarding speed75/100
Support responsiveness72/100
Licensing & trust86/100
What the Desk likes
- Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
- LegitScript approved and HIPAA compliant
- Board-certified physicians trained in obesity medicine
- Transparent dose-based pricing published on site
- Available in all 50 states
Where points come off
- Cash-pay model; medication cost billed separately by the pharmacy
- Does not dispense medication itself, so fulfillment depends on third-party pharmacies
- No compounded lower-cost alternative offered
- Specific list of supported states is not published
The Desk's briefing — C+
Best for: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.
AskRx ranks #61 of 498 providers scored — see #1, CoreAge Rx on the board.
Related dispatches
Pricing and verification reflect AskRx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on AskRx's site. Not medical advice; see our disclosure.